```

[Federal Register Volume 75, Number 244 (Tuesday, December 21, 2010)]
[Notices]
[Pages 80059-80061]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-31961]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

Advisory Committees; Tentative Schedule of Meetings for 2011

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a 
tentative schedule of forthcoming meetings of its public advisory 
committees for 2011. During 1991, at the request of the Commissioner of 
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) 
conducted a study of the use of FDA's advisory committees. In its final 
report, one of the IOM's recommendations was for the Agency to publish 
an annual tentative schedule of its meetings in the Federal Register. 
This publication implements the IOM's recommendation.

FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 32, Rm. 5290, Silver Spring, MD 20993-
0002, 301-796-8220.

SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, 
undertook a study of the use of FDA's advisory committees. In its final 
report in 1992, one of the IOM's recommendations was for FDA to adopt a 
policy of publishing an advance yearly schedule of its upcoming public

[[Page 80060]]

advisory committee meetings in the Federal Register; FDA has 
implemented this recommendation. The annual publication of tentatively 
scheduled advisory committee meetings will provide both advisory 
committee members and the public with the opportunity, in advance, to 
schedule attendance at FDA's upcoming advisory committee meetings. 
Because the schedule is tentative, amendments to this notice will not 
be published in the Federal Register. However, changes to the schedule 
will be posted on the FDA advisory committees' Internet site located at 
http://www.fda.gov/AdvisoryCommittees/default.htm. FDA will continue to 
publish a Federal Register notice 15 days in advance of each upcoming 
advisory committee meeting, to announce the meeting (21 CFR 14.20).
    The following list announces FDA's tentatively scheduled advisory 
committee meetings for 2011.

                                 Table 1
------------------------------------------------------------------------
             Committee name              Tentative date(s) of meeting(s)
------------------------------------------------------------------------
                       OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
Pediatric Advisory Committee...........  March 21, June 21-22, December
                                          5-6.
Risk Communication Advisory Committee..  February 10-11, May 5-6, August
                                          15-16, November 17-18.
Science Board to the Food and Drug       February 25, May 20, August 19,
 Administration.                          November 10.
------------------------------------------------------------------------
              CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
Allergenic Products Advisory Committee.  May 12.
Blood Products Advisory Committee......  April 28-29, August 3-4,
                                          December 1-2.
Cellular, Tissue and Gene Therapies      February 10, September 22-23.
 Advisory Committee.
Transmissible Spongiform                 Date(s), if needed, to be
 Encephalopathies Advisory Committee.     determined.
Vaccines and Related Biological          February 24-25, May 18-19,
 Products Advisory Committee.             September 20-21, November 16-
                                          17.
------------------------------------------------------------------------
                 CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
Anesthetic and Life Support Drugs        March 10.
 Advisory Committee.
Anti-Infective Drugs Advisory Committee  April date(s), if needed, to be
                                          determined.
Antiviral Drugs Advisory Committee.....  April 27-29.
Arthritis Advisory Committee...........  March 15-16, May 3.
Cardiovascular and Renal Drugs Advisory  March 31, April 1, July 26-27,
 Committee.                               October 20-21, December 13-14.
Dermatologic and Ophthalmic Drugs        April 13.
 Advisory Committee.
Drug Safety and Risk Management          Date(s), if needed, to be
 Advisory Committee.                      determined.
Endocrinologic and Metabolic Drugs       March 24.
 Advisory Committee.
Gastrointestinal Drugs Advisory          January 12, March 8, May
 Committee.                               date(s), if needed, to be
                                          determined.
Nonprescription Drugs Advisory           February 23-24.
 Committee.
Oncologic Drugs Advisory Committee.....  February 8-9, March 29-30, June
                                          28-29, July 13-14, September
                                          14-15, December 7-8.
Peripheral and Central Nervous System    January 20-21, March 10.
 Drugs Advisory Committee.
Advisory Committee for Pharmaceutical    March 2.
 Science and Clinical Pharmacology.
Psychopharmacologic Drugs Advisory       Date(s), if needed, to be
 Committee.                               determined.
Pulmonary-Allergy Drugs Advisory         March 8.
 Committee.
Advisory Committee for Reproductive      March 4, April and May date(s),
 Health Drugs.                            if needed, to be determined.
------------------------------------------------------------------------
               CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
       Medical Devices Advisory Committee (Comprised of 18 Panels)
------------------------------------------------------------------------
Anesthesiology and Respiratory Therapy   April 15.
 Devices Panel.
Circulatory System Devices Panel.......  January 25-26, February 24-25,
                                          March 24-25, April 28-29,
                                          December 8-9.
Clinical Chemistry and Clinical          November 9.
 Toxicology Devices Panel.
Dental Products Panel..................  April 12-13, September 8-9.
Ear, Nose, and Throat Devices Panel....  September 28-29.
Gastroenterology-Urology Devices Panel.  January 20-21, April 21-22,
                                          July 14-15, October 27-28.
General and Plastic Surgery Devices      February 24-25, May 12-13,
 Panel.                                   August 11-12, November 17-18.
General Hospital and Personal Use        July 29.
 Devices Panel.
Hematology and Pathology Devices Panel.  March 24-25, June 9-10,
                                          September 15-16, December 15-
                                          16.
Immunology Devices Panel...............  March 31, June 30, September
                                          29, December 1.
Medical Devices Dispute Resolution       April 8.
 Panel.
Microbiology Devices Panel.............  October 13.
Molecular and Clinical Genetics Panel..  March 3-4.
Neurological Devices Panel.............  January 27-28, March 17.
Obstetrics and Gynecology Devices Panel  May 19-20, September 22-23.
Ophthalmic Devices Panel...............  February 18.
Orthopedic and Rehabilitation Devices    April 26-27, July 8.
 Panel.
Radiological Devices Panel.............  June 17, October 27-28.
National Mammography Quality Assurance   May 6, August 9.
 Advisory Committee.
Technical Electronic Product Radiation   May 25.
 Safety Standards Committee.
------------------------------------------------------------------------

[[Page 80061]]

 
              CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
Food Advisory Committee................  March 30-31.
------------------------------------------------------------------------
                       CENTER FOR TOBACCO PRODUCTS
------------------------------------------------------------------------
Tobacco Products Scientific Advisory     January 10-11, March 17-18,
 Committee.                               May, July, September, and
                                          November date(s), if needed,
                                          to be determined.
------------------------------------------------------------------------
                     CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
Veterinary Medicine Advisory Committee.  April 11, September 12.
------------------------------------------------------------------------
               NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
------------------------------------------------------------------------
Science Advisory Board.................  November 9-10.
------------------------------------------------------------------------

    Dated: December 16, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-31961 Filed 12-20-10; 8:45 am]
BILLING CODE 4160-01-P
```